Lung Kee Group Holdings Limited (HKG:0255)

Lung Kee Group Holdings Income Statement

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	1,320	1,553	1,449	1,601	2,273
Other Revenue	-	1.09	4.43	3.54	2.32
Revenue	1,320	1,554	1,454	1,605	2,276
Revenue Growth (YoY)	-15.08%	6.92%	-9.42%	-29.47%	10.21%
Cost of Revenue	471.76	654.83	692.25	701.9	903.59
Gross Profit	848.14	899.5	761.52	903.08	1,372
Selling, General & Admin	421.14	428.58	412.58	439.14	572.67
Other Operating Expenses	314.21	324.74	295.88	295.9	344.12
Operating Expenses	892.26	921.91	878.58	888.3	1,073
Operating Income	-44.12	-22.42	-117.06	14.78	299.4
Interest Expense	-0.31	-0.28	-0.41	-0.36	-0.46
Interest & Investment Income	5.23	8.17	8.37	12.3	16.19
Currency Exchange Gain (Loss)	3.36	-1.94	-2.86	-21.37	5.24
EBT Excluding Unusual Items	-35.84	-16.47	-111.95	5.35	320.38
Gain (Loss) on Sale of Assets	12.89	2.61	7.84	9.82	8.11
Asset Writedown	-10.2	-5.5	-8.5	6.5	-13
Pretax Income	-33.15	-19.36	-112.61	21.67	315.49
Income Tax Expense	-10.53	-5.68	-40.18	5.86	87.65
Earnings From Continuing Operations	-22.62	-13.67	-72.43	15.81	227.84
Net Income	-22.62	-13.67	-72.43	15.81	227.84
Net Income to Common	-22.62	-13.67	-72.43	15.81	227.84
Net Income Growth	-	-	-	-93.06%	25.82%
Shares Outstanding (Basic)	632	632	632	632	632
Shares Outstanding (Diluted)	632	632	632	632	632
Shares Change (YoY)	0.04%	-	-	-	-
EPS (Basic)	-0.04	-0.02	-0.11	0.03	0.36
EPS (Diluted)	-0.04	-0.02	-0.11	0.03	0.36
EPS Growth	-	-	-	-93.06%	25.82%
Free Cash Flow	-	190.82	-35.72	-105.48	152.42
Free Cash Flow Per Share	-	0.30	-0.06	-0.17	0.24
Dividend Per Share	0.200	0.110	0.100	0.120	0.350
Dividend Growth	81.82%	10.00%	-16.67%	-65.71%	25.00%
Gross Margin	64.26%	57.87%	52.38%	56.27%	60.29%
Operating Margin	-3.34%	-1.44%	-8.05%	0.92%	13.16%
Profit Margin	-1.71%	-0.88%	-4.98%	0.98%	10.01%
Free Cash Flow Margin	-	12.28%	-2.46%	-6.57%	6.70%
EBITDA	117.95	139.65	46.21	167.57	447.59
EBITDA Margin	8.94%	8.98%	3.18%	10.44%	19.67%
D&A For EBITDA	162.07	162.07	163.26	152.8	148.19
EBIT	-44.12	-22.42	-117.06	14.78	299.4
EBIT Margin	-3.34%	-1.44%	-8.05%	0.92%	13.16%
Effective Tax Rate	-	-	-	27.02%	27.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.